This mutation spectrum is distinct from other previously described gene mutations in FPC (BRCA1, BRCA2, CHEK2, MSH2, MSH6), which remained undetected in the analyzed 18 FPC-CRC family members. This evidence concerns the gene BRCA2 and colorectal carcinoma.